Vox Sanguinis

The harmonization of the regulation of blood products: a European perspective
pp. 267-276(10)
Authors: Seitz, R.; Heiden, M.; Nübling, C. M.; Unger, G.; Löwer, J.

Human neutrophil alloantigens
pp. 277-285(9)
Author: Bux, J.

Improved leucoreduction of red blood cell units prepared after a 24-h hold with the platelet-rich plasma method using newly developed filters
pp. 286-291(6)
Authors: Thibault, L.; Beauséjour, A.; Jacques, A.; de Grandmont, M. J.; Lemieux, R.; Grégoire, Y.; Ducas, É.; Boucher, G.

Survival and recovery of apheresis platelets stored in a polyolefin container with high oxygen permeability
pp. 292-298(7)
Authors: Ezuki, S.; Kanno, T.; Ohto, H.; Herschel, L.; Ito, T.; Kawabata, K.; Seino, O.; Ikeda, K.; Nollet, K. E.

Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates
pp. 299-305(7)
Authors: Zhang, J. G.; Carter, C. J.; Devine, D. V.; Scammell, K.; Weiss, S.; Gyongyossy-Issa, M. I. C.

The dynamics of clot formation in fresh-frozen plasma
pp. 306-314(9)
Authors: Lawrie, A. S.; Cardigan, R. A.; Williamson, L. M.; Machin, S. J.; Mackie, I. J.

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment
pp. 315-323(9)
Authors: Osselaer, J. C.; Cazenave, J. P.; Lambermont, M.; Garraud, O.; Hidajat, M.; Barbolla, L.; Tardivel, R.; Defoin, L.; Waller, C.; Mendel, I.; Raidot, J. P.; Kandel, G.; De Meuter, R.; Fabrigli, P.; Dehenau, D.; Arroyo, J. L.; Padrón, F.; Gouezec, H.; Corral, M.; Jacquet, M.; Sundin, D.; Lin, L.; Corash, L.

A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies
pp. 324-328(5)
Authors: Fadeyi, E. A.; Adams, S.; Sheldon, S.; Leitman, S. F.; Wesley, R.; Klein, H. G.; Stroncek, D. F.

Donor's understanding of the definition of sex as applied to predonation screening questions
pp. 329-333(5)
Authors: O'Brien, S. F.; Ram, S. S.; Yi, Q.-L.; Goldman, M.

Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin
pp. 334-341(8)
Authors: Reipert, B. M.; Stellamor, M. T.; Poell, M.; Ilas, J.; Sasgary, M.; Reipert, S.; Zimmermann, K.; Ehrlich, H.; Schwarz, H. P.

Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor
pp. 342-350(9)
Authors: Lorenzon, D.; Mazzucato, M.; Abbruzzese, L.; Cilli, M.; De Angeli, S.; Degan, M.; Mambrini, G.; Piccardi, F.; Rupolo, M.; Michieli, M.; De Marco, L.; Gattei, V.; Astori, G.

Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity
pp. 351-357(7)
Authors: Reich-Slotky, R.; Colovai, A. I.; Semidei-Pomales, M.; Patel, N.; Cairo, M.; Jhang, J.; Schwartz, J.

An international collaborative study to establish the 2^nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays
pp. 358-362(5)
Authors: Baylis, S. A.; Heath, A. B.; Chudy, M.; Pisani, G.; Klotz, A.; Kerby, S.; Gerlich, W.

DIARY OF EVENTS
pp. 363-363(1)